Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 255,300 shares, a growth of 45.4% from the September 15th total of 175,600 shares. Currently, 6.3% of the company’s stock are sold short. Based on an average daily trading volume, of 4,560,000 shares, the days-to-cover ratio is currently 0.1 days.
Virax Biolabs Group Price Performance
NASDAQ VRAX traded up $0.11 during trading on Monday, hitting $1.90. 58,185 shares of the company traded hands, compared to its average volume of 1,988,397. Virax Biolabs Group has a 12 month low of $0.60 and a 12 month high of $9.00. The business has a fifty day simple moving average of $2.80 and a 200 day simple moving average of $1.66.
Virax Biolabs Group Company Profile
Featured Articles
- Five stocks we like better than Virax Biolabs Group
- Consumer Discretionary Stocks Explained
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- The Risks of Owning Bonds
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- Why Invest in High-Yield Dividend Stocks?
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.